Skip to content

Clinical trials

Phase 3 Hypotension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypotension Phase: Phase 3 Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20051
20072
20111
20122
20131
20141
20152
20162
20171
20183
20195
20212
20224
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated5
Recruiting4
Unknown status4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Theravance Biopharma3
Nantes University Hospital2
Sangart2
The Second Affiliated Hospital of Dalian Medical University2
Aretaieion University Hospital1
Ataturk University1
Brasilia University Hospital1
Centre Hospitalier Universitaire Saint Pierre1
Centre Hospitalier Universitaire, Amiens1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypotension36
Syncope5
Dizziness3
Parkinson Disease3
Pure Autonomic Failure3
Shock3
Bradycardia2
Hypertension2
Hypotension, Orthostatic2
Ischemia2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.